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Background: Diabetes with onset in younger ages affects both length of life and health status due to debilitating
and life-threatening long-term complications. In addition, episodes and fear of hypoglycaemia and of long-term
consequences may have a substantial impact on health status. This study aims to describe and analyse health-related
quality of life (HRQoL) in individuals with onset of diabetes at the age of 15—34 years and with a disease duration of 1,
8, 15 and 24 years compared with control individuals matched for age, sex and county of residence.
Methods: Cross-sectional study of 839 individuals with diabetes and 1564 control individuals. Data on socioeconomic
status and HRQoL using EQ-5D were collected by a postal questionnaire. Insulin treatment was self-reported by 94% of
the patients, the majority most likely being type 1.
Results: Individuals with diabetes reported lower HRQoL, with a significantly lower mean EQ VAS score in all cohorts of
disease duration compared with control individuals for both men and women, and with a significantly lower EQ-5Dindex
for women, but not for men, 15 years (0.76, p = 0.022) and 24 years (0.77, p = 0.016) after diagnosis compared with
corresponding control individuals. Newly diagnosed individuals with diabetes reported significantly more problems
compared with the control individuals in the dimension usual activities (women: 13.2% vs. 4.0%, p = 0.048; men: 11.4%
vs. 4.1%, p = 0.033). In the other dimensions, differences between individuals with diabetes and control individuals were
found 15 and 24 years after diagnosis: for women in the dimensions mobility, self-care, usual activities and pain/
discomfort and for men in the dimension mobility. Multivariable regression analysis showed that diabetes duration,
being a woman, having a lower education and not being married or cohabiting had a negative impact on HRQoL.
Conclusions: Our study confirms the negative impact of diabetes on HRQoL and that the difference to control
individuals increased by disease duration for women with diabetes. The small difference one year after diagnosis could
imply a good management of diabetes care and a relatively quick adaptation. Our results also indicate that gender
differences still exist in Sweden, despite modern diabetes treatment and management in Sweden.
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Diabetes with onset in younger ages affects both length
of life and health status due to debilitating and life-
threatening long-term complications [1]. In addition,
episodes and fear of hypoglycaemia and of long-term
consequences may have a substantial impact on health
status [2,3]. Health-related quality of life (HRQoL) is a
subjective assessment of health status that includes rele-
vant aspects such as general health, physical, emotional,
cognitive, and role functioning, as well as social well-
being and functioning [4]. HRQoL for individuals with
diabetes can be measured either by using a diabetes-
specific instrument which may detect subtle disease and
treatment-related effects [5-8], or generic instruments,
which enables comparisons to the general population or
other diseases [8-11]. Deciding on what type of instru-
ment to use depends on what decisions you would like
to make based on the results [12]. In order to compare
both the difference between individuals with varying
diabetes duration, and the difference between individuals
with diabetes and the general population, a generic in-
strument is the most appropriate choice. The literature
supports the use of generic HRQoL instruments for
measuring health status in individuals with diabetes, e.g.,
Short Form 36 (SF-36), Health Utility Index (HUI), or
EQ-5D [5,13,14]. The latter is a short instrument, which
can be included in any questionnaire, and it has been
used in the general population as well as on a wide
range of health conditions and treatments [15].
Several studies using EQ-5D have found that individuals
with diabetes rate their HRQoL lower than the general
population [10,14,16-20]. The majority of these studies
focused on individuals with type 2 diabetes or a mix of
individuals with type 1 or type 2 diabetes, whereas there
is a lack of studies focusing on individuals with type 1
diabetes. HRQoL is likely to be affected not only by
having diabetes but also by disease duration. Intensive
treatment in the early phases of the disease as well as
current routine treatment have been shown to reduce
or postpone the occurrence of long-term complications
[21,22], which could reduce the negative impact of the
disease on HRQoL. The increased focus on the disease
and the balancing of all routines that follow to reach a
stable glucose control may feel like a hindrance in life
and may also lead to fear of hypoglycaemic reactions [3],
which could have an impact on HRQoL. As treatment be-
comes routine, the deterioration in HRQoL can be expected
to be reduced. However, as the disease progresses complica-
tions are likely to set in and result in a gradual decrease
over time in HRQoL among individuals with diabetes
beyond that of the general population. Several studies
have shown that long-term complications of diabetes such
as ischemic heart disease, stroke, neuropathy and retinop-
athy have a negative impact on HRQoL [9,23-27].Few studies have used EQ-5D and compared results
on individuals with varying duration of diabetes. It was
found, in a Dutch study on 234 individuals with type 1
diabetes with an average disease duration of 17 years at
entry, that self-rated health and functioning over time
decreased faster for patients compared with the general
population and that HRQoL decreased significantly per
year of follow-up [14]. Patients living with a partner
reported higher HRQoL, and, unexpectedly, higher edu-
cational level was associated with lower HRQoL [20].
HRQoL for married patients decreased slower over time
compared with unmarried patients [28].
With this in mind, we hypothesised that sex, level of
education, marital status as well as onset and disease
duration would have an impact on HRQoL for individ-
uals with diabetes. We used the EQ-5D instrument to
facilitate comparison both with the control individuals
in our study and with other studies of individuals with
diabetes or other chronic diseases and the general popu-
lation where EQ-5D has been used. This study thus
aims to describe and analyse HRQoL in individuals with
onset of diabetes at the age of 15—34 years and with a
disease duration of 1, 8, 15 and 24 years, and to com-
pare with control individuals matched for age, sex and
county of residence.
Methods
Participants were selected among all registered individuals
in four incidence cohorts (1983, 1992, 1999 and 2008)
in the Diabetes Incidence Study in Sweden (DISS). Since
1983, DISS prospectively registers incident cases of dia-
betes mellitus in Sweden in the age group 15 to 34 years,
on average about 400 cases per year. Basic characteristics
of patients at diagnosis are reported by the diagnosing
doctor on a standardised form and the level of ascertain-
ment is estimated at 80–90%. The majority of the patients
in DISS (74%) are clinically classified as type 1 diabetes,
17% as type 2 and 9% as unclassified [29]. All individuals
in the respective cohorts, regardless of type of diabetes,
were included in this study. The choice of these four
cohorts was based on time since diagnosis, connected
to our hypotheses that different disease durations may
have dissimilar effects on HRQoL.
For each individual with diabetes, two control individ-
uals were randomly selected from the general population
register in which demographic characteristics on Sweden’s
population are reported by age, sex, civil status, citizen-
ship, country of birth, migration, births and deaths [30].
The control individuals were matched by age, sex and
county of residence at the time when the questionnaire
was sent out. Age was matched by choosing the two indi-
viduals with the personal identification number (based on
year, month and date of birth) closest to the individual
with diabetes, usually born on the same day or the day
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year of diabetes diagnosis, the mean age in the different
groups will differ, i.e. adding 1, 8, 15 and 24 years respect-
ively to the mean of 15–34 years in each cohort. The
HRQoL was measured by a postal questionnaire sent to all
individuals. To increase the response rate a total of three
reminders were sent to those who had not yet responded.
Survey questionnaire
The present questionnaire addressed healthcare utilisa-
tion, use of drugs, questions on socioeconomic status,
and HRQoL. It was based on a questionnaire applied in
a previous follow-up study of the 1983 and 1992 cohorts
[31], to which the EQ-5D instrument was added. For
this study, we have analysed the EQ-5D questions and
questions on socioeconomic status.
The EQ-5D instrument
The EQ-5D is a standardised instrument used to meas-
ure health outcome both on a wide range of health
conditions and treatments as well as in the general
population [10,15]. With the EQ-5D measure respon-
dents can classify their health status in five dimensions
(mobility; self-care; usual activities; pain/discomfort;
anxiety/depression) in three levels of severity (no, mod-
erate or severe problems). By this classification, there
are 243 possible unique health states that can also be
converted into a single index value (EQ-5Dindex) for
health status (1 = full health; 0 = dead). The index value
was assigned by adopting the most commonly used
value set, the York MVH A1 value set, which derives
from valuations of health states representing the average
preference of the general UK population [32]. The overall
self-rated health score, EQ VAS score, was recorded on a
scale from 0 (worst imaginable health state) to 100 (best
imaginable health state).
Data collection
The questionnaire was sent to the 1999, 1992 and
1983 year cohorts in January 2008, i.e., 8, 15 and 24 years
after diagnosis, and was answered by 721 individuals with
diabetes (response rate 58%) and 1360 corresponding
control individuals (response rate 55%). To the 2008 year
cohort and corresponding control individuals, the ques-
tionnaire was sent in 2009, i.e. 1 year after diagnosis,
and to get as close as possible to the date of diagnosis
of each individual with diabetes the questionnaire
was sent quarterly (response rate 42%; n = 143 and 38%;
n = 256 respectively). In the analyses, some individuals
were excluded due to non-sampled persons having an-
swered the questionnaire (n = 7), missing information
on sex (n = 2), missing information on age (n = 3), or
having incomplete or ambiguous answers on the EQ-5D
dimensions (n = 66; 2.6%). After exclusion, the sampleconsisted of 839 patients and 1564 control individuals.
The proportion of individuals with self-reported insulin
treatment at follow-up was 94%. The proportions of men,
individuals below 30 years of age and not being married or
cohabiting were significantly higher among the non-
responders but did not differ between individuals with dia-
betes and control individuals.
Statistical analyses
Data were analysed using SPSS. The main outcome mea-
sures were self-reported health as expressed in the five
EQ-5D dimensions, the EQ-5Dindex and the EQ VAS score.
To test whether there was a difference in sociodemographic
characteristics between patients and control individuals in
the different cohorts, and the percentage of reported prob-
lems in the EQ-5D dimensions, Pearson’s χ2-test or Fisher’s
exact test was used. The categories moderate and severe
problems were collapsed before testing. Independent sam-
ples t-test was used to test whether there were differences
in the mean EQ-5Dindex and EQ VAS score between dia-
betes individuals with different disease duration. Compari-
sons between individuals with different diabetes duration
were carried out using one-way ANOVA. Post-hoc tests
were performed with Bonferroni and Dunnett T3 tests.
The same tests were applied for the control individuals.
Multivariable regression analysis was performed to iden-
tify the independent variables (sex, diabetes diagnosis, dis-
ease duration, level of education, and marital status) that
could predict the variation in the dependent variables
EQ-5Dindex and EQ VAS score. Level of education was
dichotomised into primary school or lower and secondary
school or higher and marital status was dichotomised into
married or cohabiting and not married or cohabiting. All
statistical tests were carried out at 5% significance level.
Ethical approval
Informed consent was obtained through an accompany-
ing letter to the questionnaire explaining the study. All
analyses were carried out on group level and traceability
to individuals is therefore not possible. The study was
approved by the Regional Ethics Committee in Stockholm
(2007/214-31).
Results
Characteristics of the sample
There were no differences between patients and control
individuals regarding educational level and marital status
except that individuals with 1-year diabetes duration had
lower educational level than their control individuals
and that the proportion of married or cohabiting was
lower among individuals with diabetes 1 and 8 years after
diagnosis than among control individuals (Table 1). When
stratifying for sex, the above mentioned significances were
all attributed to men with diabetes.
Table 1 Percentage of distribution of socio-demographic characteristics of individuals with diabetes and control
individuals by disease duration
Disease duration
1 year 8 years 15 years 24 years

















n = 141 n = 247 n = 208 n = 381 n = 225 n = 419 n = 265 n = 517
% % % % % % % %
Age (year)†
16-24 45.4 44.1 6.7 6.0 - - - -
25-34 45.4 47.0 40.4 39.9 20.0 22.2 - -
35-44 9.2 8.9 52.9 54.1 50.2 48.0 18.1 18.3
45-54 - - - - 29.8 29.8 50.6 48.5
55+ - - - - - - 31.3 33.2
Age (years, mean)
Women 25.6 26.9 34.5 34.4 40.7 40.2 49.8 50.2
Men 26.1 25.5 33.7 34.2 40.2 40.1 49.7 49.7
Sex
Women 37.6 40.9 45.2 44.1 41.8 41.1 42.3 39.1
Level of education
Primary school or lower 71.0 56.3* 55.8 50.5 65.9 59.6 67.6 61.9
Secondary school or higher 29.0 43.7 44.2 49.5 34.1 40.4 32.4 38.1
Marital status
Married or cohabiting 40.3 51.0* 70.2 78.7* 74.7 75.2 74.3 75.6
Not married or cohabiting 59.7 49.0 29.8 21.3 25.3 24.8 25.7 24.4
†Age at the end of the year when the respondents received the questionnaire, i.e. 2009 for the 2008 cohort followed-up 1 year after diagnosis and 2007 for the
1983, 1992 and 1999 cohorts followed-up 8, 15 and 24 years after diagnosis.
* Significant differences were found in comparisons between patients with diabetes and control individuals with 95% significance level.
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Compared with control individuals, both women and
men with diabetes reported significantly more problems
in the dimension usual activities 1 year after diagnosis
(Table 2). Eight years after diagnosis, women with dia-
betes reported more problems in the dimension pain/
discomfort than the control individuals. Fifteen years after
diagnosis, women with diabetes reported more problems
in the dimensions usual activities and pain/discomfort
than their corresponding control individuals, and men
with diabetes reported more problems in the dimension
mobility than their corresponding control individuals.
In the dimension pain/discomfort, men with diabetes
reported less problems than the corresponding control
individuals. Twenty-four years after diagnosis, women
reported more problems in the dimensions mobility, self-
care and usual activities than female control individuals.
In general, the combined prevalence of moderate and
severe problems increased in all five dimensions by dis-
ease duration for individuals with diabetes. However,
significant differences between individuals with a dis-
ease duration of 15 or 24 years compared to those witha shorter duration, could only be seen for self-care and
pain/discomfort among women and for mobility and
pain/discomfort among men. Similar overall patterns were
found for control individuals with significantly more prob-
lems with pain/discomfort among women and with mobil-
ity and pain/discomfort among men.
EQ-5Dindex and EQ VAS score
Among women, mean EQ-5Dindex was significantly lower
for individuals with diabetes compared with control indi-
viduals 15 and 24 years after diagnosis (Figure 1). Com-
parison of women with diabetes in the different cohorts
showed significant differences in mean EQ-5Dindex be-
tween the different cohorts of women with diabetes, which
also applied for the control individuals. A similar pattern
was seen for men with diabetes as well as for male control
individuals. Post hoc tests could not detect any significant
differences between cohorts for women with diabetes,
while significant differences were found for men with
diabetes between the 1983 cohort and all other cohorts
(Figure 1). For female control individuals, significant dif-
ferences were found between the 1983 and 2008 cohorts,
Table 2 Percentage of patients with diabetes and control individuals reporting moderate and severe problems in ea EQ-5D dimension by disease duration
Diabetes duration
























n = 141 n = 247 n = 208 n = 381 n = 225 n = 419 n = 265 n = 517 pb pc
% n % n % n % n % n % n % n % n
Mobility
Women
Moderate problems 5.7 3 4.0 4 0.69 6.4 6 3.6 6 0.36 11.7 11 9.3 16 0.54 16.1 18 9.9 19 0.049 0.053 0.053
Severe problems 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.9 1 0.0 0
Men
Moderate problems 2.3 2 2.7 4 1.00 2.6 3 5.6 12 0.22 10.7 14 4.9 12 0.033 17.6 27 15.9 50 0.51 <0.001 <0.001
Severe problems 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.7 1 0.0 0
Self-care
Women
Moderate problems 0.0 0 0.0 0 - 0.0 0 0.6 1 1.00 1.1 1 2.3 4 0.43 2.7 3 0.5 1 0.023 0.048 0.059
Severe problems 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.6 1 1.8 2 0.0 0
Men
Moderate problems 1.1 1 0.0 0 0.38 1.8 2 0.9 2 0.61 3.8 5 1.6 4 0.10 3.3 5 1.9 6 0.58 0.37 0.11
Severe problems 0.0 0 0.0 0 0.0 0 0.0 0 0.8 1 0.0 0 0.7 1 1.0 3
Usual activities
Women
Moderate problems 13.2 7 3.0 3 0.048 12.8 12 7.7 13 0.18 14.9 14 6.4 11 0.029 20.5 23 8.4 16 0.001 0.19 0.42
Severe problems 0.0 0 1.0 1 0.0 0 0.0 0 2.1 2 1.7 3 2.7 3 1.5 3
Men
Moderate problems 9.1 8 3.4 5 0.033 4.4 5 6.6 14 0.64 9.9 13 7.7 19 0.31 12.4 19 8.6 27 0.14 0.090 0.065
Severe problems 2.3 2 0.7 1 1.8 2 0.9 2 2.1 3 1.2 3 3.9 6 2.9 9
Pain/discomfort
Women
Moderate problems 28.3 15 25.7 26 0.35 45.7 43 31.5 53 0.050 48.9 46 35.5 61 0.013 51.8 58 47.5 96 0.33 0.041 <0.001






















Table 2 Percentage of patients with diabetes and control individuals reporting moderate and severe problems in each EQ-5D dimension by disease duration
(Continued)
Men
Moderate problems 22.7 20 24.7 36 0.77 28.9 33 32.4 69 0.41 24.4 32 40.1 99 0.012 49.7 76 44.8 141 0.12 <0.001 <0.001
Severe problems 2.3 2 2.1 3 0.9 1 1.9 4 6.1 8 3.6 9 7.2 11 4.4 14
Anxiety/depression
Women
Moderate problems 32.0 17 30.7 31 0.60 36.2 34 27.4 46 0.13 38.3 36 29.7 51 0.057 46.4 52 36.0 73 0.056 0.29 0.41
Severe problems 3.8 2 1.0 1 2.1 2 1.8 3 8.5 8 5.2 9 1.8 2 1.0 2
Men
Moderate problems 28.4 25 23.3 34 0.14 30.7 35 24.9 53 0.13 25.2 33 31.6 78 0.22 31.4 48 23.2 73 0.064 0.43 0.28
Severe problems 6.8 6 2.7 4 3.5 4 1.4 3 1.5 2 1.2 3 3.3 5 3.2 10
a P-value for comparison between patients with diabetes and control individuals (χ2 or Fisher exact test), b p-value for comparison between patients with diabete in the different cohorts (ANOVA), c p-value for






































































ap value for comparison between women with diabetes and their corresponding control individuals.
bp value for comparison between men with diabetes and their corresponding control individuals.
Figure 1 Mean EQ-5Dindex in individuals with diabetes compared to control individuals by disease duration. Comparison (ANOVA) of the
cohorts for the different years of disease duration found significant differences between the different cohorts of women with diabetes (p = 0.022),
of female control individuals (p = 0.011), of men with diabetes (p = 0.002) and of male control individuals (p = 0.001), respectively. Post hoc tests
could not detect between which cohorts the significance for women with diabetes lay. The test, however, showed significant differences men
with diabetes between the 1983 cohort and all other cohorts (1992, p = 0.002; 1999, p = 0.007; 2008, p = 0.027), for female control individuals
between the 2008 and 1983 cohorts (p = 0.025), and for male control individuals between the 1983 cohort compared with the 2008 (p = 0.002)
and 1999 (p = 0.009) cohorts.
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and the 2008 and 1999 cohorts (Figure 1).
Mean EQ VAS scores were significantly lower for both
women and men with diabetes compared with control
individuals in all cohorts (Figure 2). Comparisons showed
no differences between the cohorts of women with differ-
ent diabetes duration, and the same applied for their
corresponding control individuals. However, for men
with diabetes significant differences were found between
the different cohorts, which was also the case for their
control individuals (Figure 2).
Variation on health-related quality of life
The multivariable regression analysis showed similar pat-
terns for both EQ-5Dindex and EQ VAS score used as
health outcomes measures (Table 3). The model showed
that sex, being diagnosed with diabetes, level of education
and not being married or cohabiting all had significant
negative impact on the health outcome measures alongwith disease duration of 8 years for EQ VAS score and dis-
ease duration of 15 and 24 years for both EQ-5Dindex and
EQ VAS score. We also tested models adding the inde-
pendent variables separately but that did not signifi-
cantly impact the final model.
Discussion
This study showed that self-reported mean EQ VAS score
was significantly lower for individuals with diabetes for all
cohorts of disease duration compared with matched con-
trol individuals. Mean EQ-5Dindex was significantly lower
for women, but not for men, 15 and 24 years after diabetes
diagnosis compared with corresponding female control in-
dividuals. One year after diagnosis, both women and men
with diabetes reported significantly more problems in the
dimension usual activities compared with corresponding
control individuals. In the other dimensions, differences
were found 15 and 24 years after diagnosis when compar-















































a p-value for comparison between women with diabetes and their corresponding control individuals.
b p-value for comparison between men with diabetes and their corresponding control individuals.
Figure 2 Mean EQ VAS scores in individuals with diabetes compared to control individuals by disease duration. ANOVA and post hoc
tests showed significant differences between the cohorts of men with diabetes (p = 0.004) which were found between the 1983 cohort and the
2008 (p = 0.020) and 1999 (p = 0.028) cohorts. Between the cohorts of male control individuals significant differences were found (p < 0.001)
between the 1983 cohort and all other cohorts (1992, p = 0.045; 1999, p = 0.040; 2008, p < 0.001). The post hoc tests could not detect any
significant differences between the cohorts for women, neither for women with diabetes nor for the control individuals.
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bility, self-care, usual activities and pain/discomfort and
for men in mobility.
To be diagnosed with diabetes is an upheaval in life
that, for the newly diagnosed, affects the EQ-5D dimen-
sion usual activities as well as mean EQ VAS score. Our
assumption was that HRQoL would be negatively affected
when treatment is in an intensive phase and that the
dimension anxiety/depression would be significantly
affected, but this was not supported by our results.
Furthermore, there was no significant difference at this
stage of the disease in EQ-5Dindex between individuals
with diabetes and corresponding control individuals. The
fact that the patients in the 1-year cohort reported their
problems a whole year after onset, can explain why there
was no discernible difference in EQ-5D dimensions com-
pared with 8 years after diagnosis except for the dimen-
sion usual activities. It is likely that the patients one
year after diagnosis have accepted the disease and some-
what adapted the new routines into their daily life. Ithas been indicated previously that although HRQoL de-
creases at onset it improves already within the first year
to levels comparable to the general population [33].
Of all EQ-5D dimensions, problems were most prom-
inent in the dimension pain/discomfort, which has also
been shown in previous studies [10,14,16-20]. As stated
previously, no significant differences were found in the
dimension anxiety/depression one year after diagnosis
between individuals with diabetes and control individuals
and this also applied 8, 15 and 24 years after diagnosis.
This could possibly be explained by a high prevalence of
problems with anxiety/depression among the general
population and also in younger age groups [10].
A decrease in EQ-5Dindex and EQ VAS score for indi-
viduals with diabetes could be seen for both women
(after 15 years) and men (after 24 years), and is consistent
with Hart et al. [14], who showed a decrease in HRQoL
per year with diabetes. Although women generally tend to
rate their HRQoL lower than men [10,17], it is noteworthy
that the difference between individuals with diabetes and
Table 3 Multiple regression analyses on EQ-5Dindex and
EQ VAS score
Dependent variable: EQ-5Dindex EQ VAS score
ß p ß p
Intercept 0.930 <0.001 89.4 <0.001
Sex
Men ref. ref.
Women −0.024 0.005 −1.8 0.014
Diabetes diagnosis
Control individuals ref. ref.
Patients with diabetes −0.025 0.007 −6.0 <0.001
Diabetes duration
1 year ref. ref.
8 years −0.023 0.099 −2.8 0.015
15 years −0.055 <0.001 −3.8 0.001
24 years −0.074 <0.001 −6.0 <0.001
Level of education
Secondary school or higher ref. ref.
Primary school or lower −0.095 <0.001 −7.5 <0.001
Marital status
Married or cohabiting ref. ref.
Not married or cohabiting −0.046 <0.001 −4.8 <0.001
R-Square 0.058 0.084
Adjusted R-Square 0.056 0.082
Number of observations 2384 2329
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after 24 years for men suggesting an earlier social stratifi-
cation in health for women with diabetes compared with
women in the general population as well as compared
with men with diabetes. Two of the cohorts in this study
(1983 and 1992) were also followed-up in the early 1990’s
[31]. Although a different instrument was used, our results
are similar to those findings with sex and socioeconomic
factors being closely associated with self-rated health 1 year
after diagnosis, as well as 8 years after diagnosis where the
association was even stronger.
Our study must be seen in relation to the development
in the management of diabetes in Sweden, which has
changed considerably during the last decades. These
changes include multiple daily injection regimens, use
of insulin pumps, new insulin analogues as well as an in-
creased proportion of self-monitoring and self-management.
Changes have also been made in the provision of health
services such as a shift from hospital inpatient care to
daycare and a shift from visits to physicians to visits to
diabetes nurses [34], and in the involvement of patients as
part of the expert team around the disease with self-
management as an important component [35]. Thus, thepatients in this study have received different types of care
dependent on the year of diagnosis. These changes in
diabetes management likely contribute to reductions or
postponements in diabetes-related complications, com-
plications which may have a negative effect on HRQoL
for individuals with diabetes.
A potential limitation of the study is the relatively
low response rate, especially in the 2008 cohort, which
could be a reflection of generally declining response
rates in population and patient surveys also experi-
enced by Statistics Sweden [36]. The strength of the
study is the large number of participants, their entry at
time of diagnosis and the long disease duration. The
differences in socio-demographic factors between re-
sponders and non-responders may suggest worse health
and lower socioeconomic status among the non-responders,
but this applies equally to individuals with and without
diabetes, implying a non-differential misclassification bias.
Including young people in study populations may be prob-
lematic for analyses on socioeconomic factors such as
educational level as some of them are still students. There
is also a potential non-differential misclassification regard-
ing marital status for the population below 20 years of age
as most of them are likely to still live with their parents.
This could lead to an overestimation of the positive effect
of being married or cohabiting. Studying four cohorts with
different disease duration can, although not truly longitu-
dinal, still give information on how the duration of dia-
betes impacts HRQoL beyond the effects of ageing.
As the excess mortality associated with diabetes [1] is
expected to decrease due to better diabetes management,
measures like HRQoL increase in importance. Many of
the national quality registers in Sweden contain patient-
reported outcomes [37]. An increased use of patient-
reported outcome measures could emphasise the patient’s
perspective and increase the opportunities for patients to
become more active in the management of their diabetes.
This could facilitate further improvement of quality and
management of healthcare services for people with dia-
betes and other chronic diseases.Conclusion
Our study confirms the overall negative impact of diabetes
on HRQoL and that the differences between individuals
with diabetes and control individuals tend to increase with
longer disease duration. HRQoL was lower already one
year after diagnosis although to a limited extent, which
could imply a good management of diabetes care and
quick adaptation by the newly diagnosed. Our results also
suggest an earlier appearance and a stronger negative im-
pact on HRQoL for women, which should be considered
in further development of diabetes management and treat-
ment in Sweden.
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